DUBLIN--(BUSINESS WIRE)--The "Global Blood Glucose Monitoring Devices Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
The blood glucose monitoring devices market is poised to grow by $ 15.60 bn during 2020-2024, progressing at a CAGR of 12% during the forecast period.
The reports on blood glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of diabetes in the world and availability of reimbursement for BGM devices. In addition, the growing prevalence of diabetes in the world is anticipated to boost the growth of the market as well.
The blood glucose monitoring devices market analysis includes product segment, end-segment segment, and geographical landscapes. This study identifies the technological advances in BGM devices as one of the prime reasons driving the blood glucose monitoring devices market growth during the next few years.
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading blood glucose monitoring devices market vendors that include Abbott Laboratories, Agamatrix Inc., ARKRAY Inc., Ascensia Diabetes Care Holdings AG, Dexcom Inc., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Medtronic Plc, Sanofi, and Terumo Medical Corp.
Also, the blood glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Key Topics Covered:
- Market Overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Five force summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- SMBG - Market size and forecast 2019-2024
- CGM - Market size and forecast 2019-2024
- Lancets - Market size and forecast 2019-2024
- Market opportunity by Product
Market Segmentation by End-user
- Hospitals and diagnostic laboratories
- Home care settings
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
- Market drivers
- Market challenges
- Market trends
- Vendor landscape
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Agamatrix Inc.
- ARKRAY Inc.
- Ascensia Diabetes Care Holdings AG
- Dexcom Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Medtronic Plc
- Terumo Medical Corp.
For more information about this report visit https://www.researchandmarkets.com/r/opunn7